Clinical trials: Paancreatic Cancer

Paancreatic Cancer

New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase

• Unknown status
• Age: 19 years and older
• Observational study

Background Carbohydrate antigen 19-9 (CA19-9) is used as a marker to predict recurrence and survival of patients with Pancreatic cancer(PDAC).

Trial name

NCT05923567

Where

South Korea

Volunteers

150 people

Sponsor

Gangnam Severance Hospital